New Malaria Drug Launched in Latin America, Southeast Asia (2/2)
[划词 ]
参考答案: Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of Acre in the Brazilian Amazon. Health care resources in the area were also expanded, including early identification of malaria. Health officials say the result was a thirty-six percent drop in cases.
Malaria is caused by a parasite which is passed to humans though mosquito bites. As many as five hundred million infections happen every year. Around sixty percent of the cases, and more than eighty percent of the deaths, happen in Africa south of the Sahara. Africa suffers more than a million deaths, mostly children.
Doctor Pecoul says his organization is supporting a study in Tanzania to see if the new drug could be used successfully in Africa. Currently in Africa, there are two first-line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in places like eastern Africa where there are high levels of resistance to several drugs.
The Drugs for Neglected Diseases Initiative began in two thousand three. It was established by the Pasteur Institute and Doctors Without Borders along with four publicly supported research organizations.
如果你想立即获取本期节目参考答案，请进入论坛参与听写 [点击参与]